Andy Sassine - 16 Dec 2024 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Dec 2024, 16:06:07 UTC
Prior SEC filing
19 Aug 2024
Next SEC filing
07 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ilan Katz, attorney-in-fact

Key filing fact

Andy Sassine filed Form 4 for Arcturus Therapeutics Holdings Inc. (ARCT) on 18 Dec 2024.

Key facts

  • This page summarizes Andy Sassine's Form 4 filing for Arcturus Therapeutics Holdings Inc. (ARCT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 Dec 2024, 16:06.

Change

  • Previous filing in this sequence was filed on 19 Aug 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARCT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+60,000
Change %
Price
$0.000000
Shares after
60,000
Date
16 Dec 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
60,000
Exercise price
$16.24
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents options to purchase shares of common stock granted pursuant to the Company's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended.

Footnote F2

The shares underlying this option vest 25% on December 16, 2025, the first anniversary of the date of grant, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .